The Angeles Clinic and Research Institute
The Angeles Clinic and Research Institute, a Cedars-Sinai Affiliate, has established an international reputation for developing new cancer therapies, providing the best in experimental and traditional treatments, and expertly guiding and training the next generation of clinicians.
Date: Saturday – May 11, 2024
Time: 12:00 PM (EST) | 11:00 AM (CST) | 10:00 AM (MST) | 9:00 AM (PST)
(double-check your local time with this time zone converter)
Format: Presented both virtually and in-person; Registration is required for both formats; please register below
Symposium Location: The Angeles Clinic and Research Institute, 11800 Wilshire Blvd, Los Angeles, CA 90025, 310-231-2120
This symposium is an opportunity for patients and caregivers to learn about melanoma from medical professionals and fellow patients, caregivers, and survivors. This event is FREE and open to all and will be presented in-person and virtually.
Presenters & Topics
Welcome and Introductions @ The Angeles ClinicOmid Hamid, MD
Chief, Translational Research & Immuno-Oncology
Intelligent Immunotherapy Innovations in Initial Therapy
Justin T. Moyers, MD
The Angeles Clinic and Research Institute
Phase I & Experimental Therapeutics Program
Mucosal, Acral, Uveal Futures – Time to Invest!
Inderjit Mehmi, MD
Medical Oncology
The Angeles Clinic & Research Institute, A Cedars-Sinai Affiliate
NeoAdjuvant & Adjuvant Therapy: Questions Getting Answered
Sapna Patel, MD
Chair SWOG Melanoma Committee, University of Colorado
Dr William Robinson Endowed Chair, Professor in Cancer Research
Clinical Trial Options – New Data, Future Therapies
Ryan J. Sullivan, MD
Assistant Professor, Medicine, Harvard Medical School
Cellular Therapy: TIL Tomorrow and Further
Mark B. Faries, MD
Co-Director, Melanoma Research Program
The Angeles Clinic & Research Institute, A Cedars-Sinai Affiliate
Radiation Therapy in Melanoma, Novel Paradigms
Anthony T. Nguyen, MD PhD
Department of Radiation Oncology
Cedars-Sinai Medical Center
SURVIVORSHIP: Seeking Answers
Omid Hamid, MD – Co-Director, Melanoma Research Program
Samantha Guild – President, AIM at Melanoma